Union Budget 2025-26: A roadmap for India’s pharmaceutical leadership

Read more

Understanding opportunities and challenges for SMEs after breather on Schedule M deadline

Read more

Bolstering India’s healthcare innovation in cancer, rare diseases: How Budget 2025 can make a difference?

Read more

Lupin gains USFDA approval for Abacavir, Dolutegravir and Lamivudine Tablets for Oral Suspension

Read more

India’s biopharma industry needs to become a little bit more ambitious

Read more

GlobalData tracks 40 yrs of innovation in USFDA review designations

Read more

Emcure Pharma inaugurates R&D centre in Ahmedabad

Read more

Kotak Alternate Asset Managers announces first close of Kotak Life Sciences Fund

Read more

Piramal Critical Care launches Chlorpromazine Hydrochloride for Injection, USP in the US

Read more

USFDA designates Zydus’ Usnoflast an orphan drug for ALS treatment

Read more